- Report
- April 2021
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- August 2022
- 116 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- February 2024
- 150 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- March 2025
China
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Report
- March 2025
United Kingdom
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Report
- January 2021
- 221 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Book
- March 2018
- 858 Pages
- Report
- March 2025
Europe
From €3808EUR$3,990USD£3,191GBP
- Report
- March 2025
Global
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Report
- March 2025
North America
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Report
- March 2025
Europe
From €1999EUR$2,095USD£1,675GBP
€3808EUR$3,990USD£3,191GBP
- Report
- July 2024
- 91 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- November 2023
- 121 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- February 2024
- 84 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP

Sulfonamide is a type of antibiotic used to treat bacterial infections. It works by inhibiting the growth of bacteria, preventing them from reproducing and spreading. Sulfonamide is used to treat a wide range of bacterial infections, including urinary tract infections, skin infections, and respiratory infections. It is also used to prevent certain types of malaria. Sulfonamide is available in both oral and intravenous forms, and is often used in combination with other antibiotics.
Sulfonamide is a widely used antibiotic, and is often prescribed as a first-line treatment for bacterial infections. It is generally well-tolerated, with few side effects. However, it is not effective against all types of bacteria, and some bacteria have developed resistance to it.
Some companies in the Sulfonamide market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more